Trabectedin

曲贝替定

Report date: 2026/05/06 20:02:28
NME

Base Information

Drug NameTrabectedin
Drug Alias Name他比特啶trabectedinatrabectedinum曲贝克替定Yondelis +[8] 
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionAlkylating agentsApoptosis inducersDNA minor groove binders +[4] 
TargetsDNA minor grooveDNA
Therapy Area/IndicationsSolid tumoursBreast DiseasesSkin Diseases +[31] 
Global Approved IndicationsOvarian NeoplasmsSarcoma
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2007/09/17
Country/TerritoryBelgiumCanadaUnited States +[27] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPending
Originator CompaniesPharma Mar Sa
China Registration ClassN/A

Develop Information

Active CompaniesLudwig Maximilians University Of MunichJanssen Products, LpApotex Inc +[5] 
Inactive CompaniesJanssen-Cilag International NvJanssen Pharmaceutica NVXian Janssen Pharmaceutical Ltd +[13] 
Active IndicationsOvarian NeoplasmsBone NeoplasmsDesmoplastic Small Round Cell Tumor +[9] 
Inactive IndicationsSolid tumoursBreast DiseasesSkin Diseases +[22] 

Other Information

ATC CodeL01CX01
Related LinksWikipediaDrugBankKEGG